| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.3M | +25.3% |
| SG&A Expense | $4.8M | -15.5% |
| Operating Income | -$12.1M | -5.2% |
| Pre-tax Income | -$11.9M | -6.6% |
| Net Income | -$11.9M | -6.6% |
| EPS (Basic) | -$3.87 | +54.4% |
| EPS (Diluted) | -$3.87 | +54.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -74.7% |
| Current Assets | $1.9M | -66.7% |
| Total Assets | $3.2M | -44.2% |
| Current Liabilities | $1.5M | +109.8% |
| Total Liabilities | $1.5M | +92.2% |
| Stockholders' Equity | $1.7M | -66.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.2M | -39.5% |
| Capital Expenditures | $3K | +16.9% |
| Investing Cash Flow | -$3K | -16.9% |
| Financing Cash Flow | $7.7M | +23.4% |
| Free Cash Flow | -$11.2M | -39.5% |